Medium-term
Life sciences and trial feasibility exploration
Do not lead with synthetic control arms.
Synset is not a generic synthetic-data vendor. It is most useful when clinical AI teams need realistic, longitudinal, scenario-controlled cohorts with hidden truth, controlled perturbations, release certificates, and audit-ready evidence.
01 / First productized service
Buyer
Clinical AI assistant vendors, clinical RAG vendors, health-system AI governance teams, medical-search and evidence-support products.
What Synset sells
Certified synthetic case packs with hidden truth, red flags, contraindications, missing-context traps, longitudinal deterioration, counterfactual variants, and a governance-ready failure report.
Differentiation
Ordinary test sets mostly measure retrospective answer quality. Synset can create controlled clinical futures and edge cases that test whether an assistant misses a contraindication, fails to ask for missing context, gives unsafe reassurance, or behaves inconsistently under clinically meaningful counterfactual changes.
02 / Investor-proof evidence asset
Buyer
Investors, clinical AI vendors, regulated AI teams, health systems, strategic partners.
What Synset sells
A case-study program showing where ordinary validation looked fine but certificate-gated scenario cohorts exposed a reproducible failure mode.
Differentiation
This is a planned public evidence asset or design-partner study unless a completed partner result is explicitly marked as completed.
03 / Second near-term commercial wedge
Buyer
Ambient scribe companies, clinical summarization vendors, care-navigation tools, coding/CDI vendors, health-system AI governance teams.
What Synset sells
Synthetic mini-charts with structured ground truth plus note and dialogue sidecars, then an audit report showing unsupported assertions, omitted critical facts, contradictions, medication/lab mismatches, and temporal-order errors.
Differentiation
Synset can generate notes and dialogues conditioned on structured state and workflow context, then validate whether downstream summaries remain grounded.
04 / Governance and regulated-AI wedge
Buyer
Regulated healthcare ML vendors, risk-model companies, payers, health systems, clinical analytics teams.
What Synset sells
Certified scenario cohorts that test calibration, false negatives, subgroup performance, drift, missingness robustness, and risk-coverage behavior under rare or longitudinally complex conditions.
Differentiation
A held-out test set shows performance on yesterday's distribution. Synset asks how the model behaves under controlled future shifts, missingness patterns, rare strata, or pathway changes.
05 / Recurring SaaS-style product
Buyer
Vendors shipping frequent model updates, health-system AI governance groups, regulated software teams.
What Synset sells
A fixed certified audit suite rerun after each model update to detect regression, drift, degraded calibration, new hallucination modes, or worsened subgroup behavior.
06 / Fast monetization wedge
Buyer
Coding automation vendors, CDI vendors, revenue-cycle companies, payers, health systems.
What Synset sells
Synthetic charts with known diagnoses, procedures, medications, labs, notes, and claims-style artifacts, then audits coding models for missed codes, unsupported codes, upcoding risk, diagnosis hallucination, and note-structured-data inconsistency.
07 / Long-term platform expansion
Buyer
AI/ML development teams, clinical foundation-model teams, risk-model vendors, triage vendors, payer analytics teams.
What Synset sells
Synthetic longitudinal trajectories, imputed missing data, counterfactual futures, and rare-edge-case cohorts used to train, fine-tune, or harden models.
Training-data claims require stronger validation than audit claims. Synset presents this as model-hardening support, not guaranteed performance improvement.
08 / Developer and health IT use case
Buyer
EHR vendors, interoperability startups, digital health companies, app developers, payer/provider integration teams.
What Synset sells
Clinically coherent, longitudinal, scenario-controlled, certificate-bearing FHIR-style test populations for complex workflows.
Differentiation
The focus is complex workflows such as ICU, ED triage, chronic disease, cardiometabolic, oncology, pregnancy, medication safety, and care transitions, not generic dummy data.
09 / Bigger-ticket, slower enterprise sale
Buyer
Health-system AI governance committees, innovation teams, clinical informatics groups, academic medical centers.
What Synset sells
An internal, privacy-safe sandbox for testing AI models, vendor tools, local workflows, and prospective edge cases before deployment.
Differentiation
Local validation architecture can keep raw data inside the institution, use read-only ingress, compute local metrics, and export protected metric payloads rather than patient records.
10 / Enterprise endgame
Buyer
Health systems, hospital networks, model vendors with deployed enterprise clients, regulatory/governance platforms.
What Synset sells
Local validation agents that generate synthetic evaluation artifacts, execute models locally, compute certificate-conditioned metrics, and transmit protected aggregate payloads to central dashboards.
Differentiation
Privacy-preserving AI assurance infrastructure rather than merely synthetic-data generation.
11 / Specialized stress-test product
Buyer
Rare disease startups, pharma, clinical AI vendors, regulatory/scientific groups.
What Synset sells
Clinically plausible rare-condition or rare-event cohorts with known labels and certificate summaries.
Use as stress-test support for rare scenarios, not an accurate real-world rare disease simulator.
Request rare-scenario packEach item is a roadmap, partner-driven, or medium-term direction unless the capability is separately marked as implemented and validated.
Medium-term
Do not lead with synthetic control arms.
Partner-driven
Requires partner-specific evidence framing.
Medium-term
Scenario training support, not clinical advice.
Roadmap
Future workflow and behavior modeling direction.
Medium-term
Scenario perturbation extension.
Roadmap
Not a current validated claim.
Roadmap
Not a current validated claim.
Partner-driven
Depends on partner data-handling architecture.
Synset can start with an assistant audit, note-grounding audit, risk-model stress test, coding/CDI audit, regression suite, or FHIR/EHR sandbox blueprint.